-
The risk of fatty liver progression to liver cancer is as high as 23%! The sub-issue of "Nature" takes stock of 3 major developments
Time of Update: 2023-02-03
Screenshot credit: Nature ReviewsGastroenterology & HepatologyFocus on research progressFirst, artificial intelligence can quantitatively evaluate liver fibrosis after anti-NAFLD treatment through second harmonic (SHG)/two-photon excitation fluorescence (TPEF) microscopic imaging technology.
-
NEJM: Cemiplimab for Recurrent Cervical Cancer
Time of Update: 2022-03-04
Survival was significantly longer with cemiplimab in patients with relapsed cervical cancer after first-line platinum-based chemotherapy than with continuation of single-agent chemotherapy .
Survival was significantly longer with cemiplimab in patients with relapsed cervical cancer after first-line platinum-based chemotherapy than with continuation of single-agent chemotherapy .
-
Keystone Pharmaceuticals and Stone Burning Medicine have reached a partnership on the accompanying diagnosis of Pralsetinib China
Time of Update: 2020-07-19
On May 30, 2020, ASCO online meetings released the latest clinical data on non-small cell lung cancer (NSCLC) in the ARROW study being conducted worldwide, including the population of patients who rec
-
Xi'an Janssen new anti AIDS drug puzeli is listed in China
Time of Update: 2018-07-23
On July 23, Xi'an Janssen Pharmaceutical Co., Ltd., a subsidiary of Johnson & Johnson Pharmaceutical Co., Ltd., announced that the State Drug Administration has officially approved the use of puzeli ®
-
Onion extract helps lower blood sugar and cholesterol
Time of Update: 2015-08-18
Recently, at the 97th American Society of Endocrinology held in San Diego, researchers from Delta State University said that when combined with metformin, an antidiabetic drug, onion extract can signi
